Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Androgenetic alopecia doesn't increase the risk of heart-related health issues.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Higher air pollution increases the risk of alopecia areata.

Fibrosing alopecia can be stabilized or improved with anti-inflammatory treatments and hair growth agents.

Ultraviolet techniques help identify Grover’s Disease, which may be underdiagnosed in young people and females.

Low-dose oral minoxidil does not significantly affect blood pressure in patients with hair loss and hypertension.

Vaccination helps reduce long COVID symptoms in women with PCOS.

Leflunomide may reduce the risk of alopecia areata, while methotrexate, cyclosporine, and rituximab may increase it.

Low-dose oral minoxidil is safe for the heart in the short term for hair loss patients.

Baricitinib is more effective than tofacitinib for hair regrowth in alopecia patients.

Alopecia areata patients have higher risks of infections, lymphoma, heart issues, and death.

Azathioprine is a safe and effective long-term treatment for severe alopecia areata, significantly improving hair regrowth.

Janus Kinase inhibitors are effective and safe for treating alopecia areata, but more research is needed.

Most patients improved in both atopic dermatitis and alopecia areata with certain treatments, but some had worsened symptoms, suggesting personalized care is needed.

Two L-PRP treatments improve hair density in mild to moderate alopecia.

Baricitinib effectively promotes hair regrowth in alopecia areata patients with mild side effects.

Minoxidil with betamethasone is the most effective for hair regrowth in alopecia areata.

Baricitinib is effective for severe alopecia areata but has some side effects.

5-alpha reductase inhibitors don't increase breast cancer or benign breast disorder risk in women.

Omega-3 fatty acids may not help and could harm hair loss improvement in middle-aged or elderly men.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

Surgery for burn scar alopecia often involves multiple procedures, and treatment options should be more accessible to improve self-image.

Neck burn scar contracture recurrence is more likely with larger neck defects, and closer follow-up can help detect it sooner.

Transgender and gender diverse youth often have skin issues like acne and scarring, but few get referred to dermatologists.

Having an appendectomy may increase the risk of developing alopecia areata.

Many severe COVID-19 patients experienced temporary hair loss, but most regrew hair within six months.

Bicalutamide does not significantly affect liver enzymes and is a safe anti-androgen option for transfeminine individuals.

Topical minoxidil and dietary supplements improved hair regrowth in children with hair loss from chemotherapy.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.